Moodivate for Depression

Not yet recruiting at 1 trial location
LW
Overseen ByLarry W. Hawk, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: State University of New York at Buffalo
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a mobile health app called Moodivate to evaluate its effectiveness in helping people with depression. The researchers aim to determine whether using the app remotely or in person affects the treatment's success. Participants will be divided into groups for either remote or in-person sessions and monitored for three months. The trial suits individuals who check their emails or texts daily, own a smartphone, and experience elevated depressive symptoms impacting their daily lives. As an unphased trial, this study provides an opportunity to contribute to innovative research that could enhance mental health treatment options.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. Please consult with the study team for more details.

What prior data suggests that the mobile health application (Moodivate) is safe for treating depression?

Research shows that Moodivate, a mobile app designed to help manage depression, is generally well-received by users. In past studies, people using similar mental health apps have not reported major negative effects. Moodivate employs a method called behavioral activation, which encourages activities that can boost mood. This approach has proven safe and effective in managing depression symptoms.

No strong evidence indicates serious side effects from using Moodivate. Instead, users often find it helpful to track their mood and choose activities that align with their personal values, creating a positive experience. Overall, mobile health apps like Moodivate are considered safe for those looking to manage depression symptoms.12345

Why are researchers excited about this trial?

Unlike traditional depression treatments, which often involve medication or face-to-face therapy sessions, Moodivate is a mobile health application designed to provide remote support. Researchers are excited about Moodivate because it offers a convenient and accessible way for individuals to manage their depression, potentially reaching patients who might not have access to regular in-person therapy. Additionally, Moodivate could offer real-time feedback and personalized interventions, which are not typically available with standard treatments like antidepressants or scheduled therapy sessions. This trial aims to explore how different combinations of remote and in-person interactions impact treatment effectiveness, offering insights into flexible treatment modalities for depression.

What evidence suggests that the Moodivate mobile health application is effective for depression?

Research has shown that digital health apps like Moodivate can help manage depression. Some studies found that these apps lessen symptoms by offering tools to track mood and use helpful strategies. Users often report feeling more in control of their mental health. While specific data for Moodivate isn't widely available yet, early feedback from similar apps suggests a positive effect on mood and emotional well-being. Participants in this trial will use the Moodivate app, which is considered effective because it provides immediate support and guidance, crucial for those dealing with depression.678910

Are You a Good Fit for This Trial?

This trial is for adults who may have depression and are willing to participate in either remote (online) or in-person study visits. Participants must be able to use a mobile health app and complete assessments over three months.

Inclusion Criteria

Stable mailing address within accessible range (1.5 hours) of each study site per self report
Able to read, speak, and verbally comprehend English
Currently own an iOS- or Android-compatible smartphone
See 4 more

Exclusion Criteria

Consumption of >28 alcohol-containing drinks per week
Suicide attempt with at least some wish to die in past 3 months
Mental illness such as schizophrenia, bipolar disorder, or major depression that led to hospitalization in the past 30 days
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1 month
1 brief screen (remote or in-person)

Intake

Detailed consent and eligibility assessment completed; participants randomized to Remote or In-Person Intake Groups

1 month
1 intake visit (remote or in-person)

Treatment and Assessment

Participants undergo 5 treatment/assessment visits, either remote or in-person, based on randomization

3 months
5 visits (remote or in-person)

Follow-up

Participants are monitored for retention, treatment utilization, and biospecimen completion

3 months

What Are the Treatments Tested in This Trial?

Interventions

  • mobile health application (Moodivate)

Trial Overview

The study compares the effectiveness of using a mobile health app called Moodivate with remote versus in-person treatment and assessment methods for managing depression. Participants are randomly assigned to groups.

How Is the Trial Designed?

4

Treatment groups

Experimental Treatment

Group I: REMOTE intake BUT IN-PERSON treatment/assessmentExperimental Treatment1 Intervention
Group II: REMOTE intake AND REMOTE treatment/assessmentExperimental Treatment1 Intervention
Group III: IN-PERSON intake, BUT REMOTE treatment/assessmentExperimental Treatment1 Intervention
Group IV: IN-PERSON intake AND IN-PERSON treatment/assessmentExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

State University of New York at Buffalo

Lead Sponsor

Trials
279
Recruited
52,600+

Medical University of South Carolina

Collaborator

Trials
994
Recruited
7,408,000+

National Center for Advancing Translational Sciences (NCATS)

Collaborator

Trials
394
Recruited
404,000+

Wake Forest University Health Sciences

Collaborator

Trials
1,432
Recruited
2,506,000+

Citations

1.

en.wikipedia.org

en.wikipedia.org/wiki/Data

Data

Data is a collection of discrete or continuous values that conveys information, describing the quantity, quality, fact, statistics, other basic units of ...

Data | Open Access Journal

Data is a peer-reviewed, open access journal on data in science, with the aim of enhancing data transparency and reusability. The journal publishes in two ...

3.

data.org

data.org/

data.org - Data and AI for mission

data.org coordinates across sectors to support and advance visionary—yet practical—solutions to drive impact through data and AI.

4.

data.gov

data.gov/

Data.gov Home - Data.gov

Here you will find data, tools, and resources to conduct research, develop web and mobile applications, design data visualizations, and more.

Annual Progress Reports - Data Dashboard and Downloads

This report includes data on jurisdictions' progress towards their housing goals, including data on all housing development applications, entitlements,

Evaluation of a Mobile Therapy for Elevated Depressive ...

Moodivate is a mobile app for individuals with elevated symptoms of depression. Within the app, users identify values, create activities, ...

Validation of an mHealth App for Depression Screening and ...

This paper presents the external validation of Psychologist in a Pocket (PiaP), an Android-based mental mHealth app which supports traditional ...

(PDF) Validation of an mHealth App for Depression ...

Data collected through mobile health tools may be used to support the identification of depression symptoms in pregnancy.

In study, CBT app MoodHacker matches web-based ...

MoodHacker takes a self-management approach to depression management. Users can track their mood on the app along with other factors like food ...

Project Details

This project aims to develop and design MoodRing, a technology platform, which will gather information about how an adolescent uses their mobile phone and ...